In-Person Access Only | Earn 8.5 CME Credits & MOC Points

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

The Third Annual Hematology Think Tank: Now and Tomorrow will take place April 30–May 2, 2027, in Chicago, Illinois. This highly interactive educational forum brings together internationally recognized leaders in malignant hematology to examine the current state of care while exploring the innovations that will define the future of the field. Through expert presentations, multidisciplinary panel discussions, audience engagement, and select debates, faculty will address emerging data, evolving treatment paradigms, translational research, cellular therapies, precision medicine, and the practical challenges of integrating new evidence into clinical practice. Covering a broad spectrum of hematologic malignancies— including leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and CAR T-cell therapy—the program is designed to foster meaningful collaboration and provide actionable insights that attendees can immediately apply to patient care. This program will be hosted as an in-person event only.

Conference Agenda
Friday, April 30, 2027 - Sunday, May 2, 2027

Agenda coming soon!

Agenda Subject To Change. All times at CST.

• Learning Objectives

  • Review recent clinical advances in the treatment of cancers, with a focus on the most relevant data from recent studies and clinical trials.

  • Evaluate the role of emerging therapies in cancer treatment, including new medications, targeted therapies, and immunotherapies.

  • Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.

  • Assess and manage side effects and toxicities associated with current and emerging therapies in cancer patients.

  • Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating cancers.

• Accreditation Information | 8.5 Credits

• What to Expect | In-Person Learners

  • Complimentary registration for healthcare professionals

  • Expert-led Think Tank discussions featuring internationally recognized hematology leaders

  • Interactive multidisciplinary panels exploring today's challenges and tomorrow's innovations

  • Practical clinical insights spanning malignant hematology, cellular therapies, and precision medicine

  • Thought-provoking debates on emerging areas of clinical controversy

  • Opportunities to engage directly with faculty through audience discussion and Q&A

  • Networking with leading clinicians, researchers, and industry partners

  • The latest advances in hematology research, novel therapeutics, biomarker-driven care, and clinical trial data